2.筋ジストロフィーの分子機構と治療戦略

Saved in:
Bibliographic Details
Published in日本内科学会雑誌 Vol. 105; no. Suppl; pp. 77a - 83a
Main Author 戸田, 達史
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本内科学会 2016
Subjects
Online AccessGet full text
ISSN0021-5384
1883-2083
DOI10.2169/naika.105.77a

Cover

Author 戸田, 達史
Author_xml – sequence: 1
  fullname: 戸田, 達史
  organization: 神戸大学大学院医学研究科神経内科学/分子脳科学
BookMark eNo9kD1Lw0Acxg-pYK0d_Rip95K7XNykVC0UHNQ5_HO909RaS1IHxyYggYK4dHByEN-GOjgp9tscTUe_gqWK0_PAAz_4Peuo1LvoaYQ2Ca5RIvytHkRnUCOY1zwPVlCZSMkciiUroTLGlDicSXcNVZMkCrHLBJeEuWW0Tb-nN_PJyKYfNv20WW6zic3GNn2w2dQO32b59WxyW7zeF88jO3wp3r_md2mRP83Hjxto1UA30dW_rKDj3cZRfd9pHew16zstp0MEw44JmW-EIpwrocBz_RAMENVmpu26lPuh3zaeDjkjlBohBYdQAvE05kZi0IpVUOOX20kGcKKDfhydQ3wVQDyIVFcHS_NgYR4cXvb73WVbfPC_q1OIgw6wH9ggbJg
ContentType Journal Article
Copyright 2016 一般社団法人 日本内科学会
Copyright_xml – notice: 2016 一般社団法人 日本内科学会
DOI 10.2169/naika.105.77a
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1883-2083
EndPage 83a
ExternalDocumentID article_naika_105_Suppl_105_77a_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
DIK
F5P
JSF
OK1
RJT
ID FETCH-LOGICAL-j1630-fb39f6c155c6ca749bafa1cd3fd44259b9df7eb53122f6865ab8a17e05f80aec3
ISSN 0021-5384
IngestDate Wed Sep 03 06:28:55 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue Suppl
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j1630-fb39f6c155c6ca749bafa1cd3fd44259b9df7eb53122f6865ab8a17e05f80aec3
OpenAccessLink https://www.jstage.jst.go.jp/article/naika/105/Suppl/105_77a/_article/-char/ja
ParticipantIDs jstage_primary_article_naika_105_Suppl_105_77a_article_char_ja
PublicationCentury 2000
PublicationDate 20160000
PublicationDateYYYYMMDD 2016-01-01
PublicationDate_xml – year: 2016
  text: 20160000
PublicationDecade 2010
PublicationTitle 日本内科学会雑誌
PublicationTitleAlternate 日内会誌
PublicationYear 2016
Publisher 一般社団法人 日本内科学会
Publisher_xml – name: 一般社団法人 日本内科学会
References 1) GeneTable of Neuromuscular Disorders. http://www.musclegenetable.fr
9) Inamori K, et al: Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Science 335: 93-96, 2012.
6) Malicdan MC, et al: Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model. Nat Med 15: 690-695, 2009.
2) 金川 基: ジストログリカンの糖鎖機能と筋ジストロフィー. 生化学 86: 452-463, 2014.
3) Mendell JR, et al: Eteplirsen for the treatment of Duchenne muscular dystrophy. Ann Neurol 74: 637-647, 2013.
4) Welch EM, et al: PTC124 targets genetic disorders caused by nonsense mutations. Nature 447: 87-91, 2007.
10) Taniguchi-Ikeda M, et al: Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy. Nature 478: 127-131, 2011.
5) Bogdanovich S, et al: Functional improvement of dystrophic muscle by myostatin blockade. Nature 420: 418-421, 2002.
7) Kobayashi K, et al: An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394: 388-392, 1998.
8) Yoshida-Moriguchi T, et al: O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Science 327: 88-92, 2010.
References_xml – reference: 7) Kobayashi K, et al: An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394: 388-392, 1998.
– reference: 3) Mendell JR, et al: Eteplirsen for the treatment of Duchenne muscular dystrophy. Ann Neurol 74: 637-647, 2013.
– reference: 4) Welch EM, et al: PTC124 targets genetic disorders caused by nonsense mutations. Nature 447: 87-91, 2007.
– reference: 5) Bogdanovich S, et al: Functional improvement of dystrophic muscle by myostatin blockade. Nature 420: 418-421, 2002.
– reference: 6) Malicdan MC, et al: Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model. Nat Med 15: 690-695, 2009.
– reference: 9) Inamori K, et al: Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Science 335: 93-96, 2012.
– reference: 10) Taniguchi-Ikeda M, et al: Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy. Nature 478: 127-131, 2011.
– reference: 2) 金川 基: ジストログリカンの糖鎖機能と筋ジストロフィー. 生化学 86: 452-463, 2014.
– reference: 8) Yoshida-Moriguchi T, et al: O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Science 327: 88-92, 2010.
– reference: 1) GeneTable of Neuromuscular Disorders. http://www.musclegenetable.fr
SSID ssib043658134
ssj0066765
ssib002821954
ssib005879745
ssib007485360
ssib058493862
ssib000940260
ssib002484664
Score 2.0666826
SourceID jstage
SourceType Publisher
StartPage 77a
SubjectTerms Duchenne型筋ジストロフィー
アンチセンス治療
リードスルー治療
福山型筋ジストロフィー
Title 2.筋ジストロフィーの分子機構と治療戦略
URI https://www.jstage.jst.go.jp/article/naika/105/Suppl/105_77a/_article/-char/ja
Volume 105
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本内科学会雑誌, 2016/02/20, Vol.105(Suppl), pp.77a-83a
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1883-2083
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssib007485360
  issn: 0021-5384
  databaseCode: KQ8
  dateStart: 19130101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07a9xAEBaOAyFNyJO8cZGtgpzT6rG7KQLSRYcJOCFggzux0knFFZcQzk0630E4MIQ0LlKlCHkVTpEqIf43wndl_kK-WenOOnAROyDE3GhnZmd3dTMjdmcs616Rujx3lbYzXRS2x_PMVmmg8bpnsEY5lSykQHH9abC26T3Z8reWzjxr7FraHqSr2etjz5WcZlaBw7zSKdkTzOycKRCAMb-4Y4Zx_6c55izusKjNZMxiwcLHTEYsdpnkLJIzQBkAl6wBNKsA5ddtQrfGgBUBDgvB0CcSGRAAEtViccBCxVTHAGImC40lYSLIiqgbShFPYEAeBgYDDn7TC6anCh32DdBmYduIA4lvFAGJU8slDh51TIUshvTIPALnkMn5B95aGikNUjRv0cqh9ugefhNzDBRvfuKozl6a5WgkSNrzAcbU67bpBZBmGCCTRggqVmMGfIjr_um0aJoJ7tiwBNWXjryyDFK6WHxV1Z256Wj5jXfE1GFtGAMhdNOvcPVxJos7AWV87dOBMSq6vDqnWsgCXq-xxLRL0C4x0gwEimT2nM7qJT0EDGe5gOtFuxSeN_xt5VEOuYZ_JhfKCyD-dpr5AX0pVLMcgvDg3R3Rey78V-covyCcWeXKYJ6_jfZPVyVE6vGsktySyg8WFIb710MwNNtIaXy7jYvWhTooWwkr7S5ZSz192Tq3Xm87uWI95H8O3k73d8vhz3L4qxyNy9F-Odorhx_L0UG58_1w_OZw_93k24fJl91y5-vkx-_p--Fk_Hm69-mqtdmJN9prdl10xO4hNGnZ-PNSRZDBzc6CTAtPpbrQTtZ1i64H-6ZS1S1EnsJ0cV4EMvB1KrUj8pZfyJbOM_eatdx_0c-vWysi0FwqxEsI2z1PcJ0JldPGCc19zbv-DetRpXXyssosk5xwlm_-L4Nb1nl636pPiret5cGr7fwOnOxBetcsnL-deard
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2%EF%BC%8E%E7%AD%8B%E3%82%B8%E3%82%B9%E3%83%88%E3%83%AD%E3%83%95%E3%82%A3%E3%83%BC%E3%81%AE%E5%88%86%E5%AD%90%E6%A9%9F%E6%A7%8B%E3%81%A8%E6%B2%BB%E7%99%82%E6%88%A6%E7%95%A5&rft.jtitle=%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E6%88%B8%E7%94%B0%2C+%E9%81%94%E5%8F%B2&rft.date=2016&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=0021-5384&rft.eissn=1883-2083&rft.volume=105&rft.issue=Suppl&rft.spage=77a&rft.epage=83a&rft_id=info:doi/10.2169%2Fnaika.105.77a&rft.externalDocID=article_naika_105_Suppl_105_77a_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-5384&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-5384&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-5384&client=summon